Side-by-side comparison of AI visibility scores, market position, and capabilities
Finch Therapeutics develops microbiome-based medicines targeting the gut-brain and gut-immune axis with programs in autism spectrum disorder and C. difficile.
Finch Therapeutics is a clinical-stage biotechnology company founded in 2015 that develops microbiome medicines targeting the relationship between the gut microbiome and systemic diseases. The company is focused on two primary therapeutic areas: gastrointestinal infections including C. difficile and conditions involving the gut-brain axis including autism spectrum disorder where gut microbiome alterations have been associated with symptom severity. Finch's lead microbiome program CP101 targets recurrent C. difficile infection, competing in the same emerging microbiome therapeutics space as Seres Therapeutics. The company also conducts research on the COMET platform for autism spectrum disorder, exploring whether microbiome restoration can improve behavioral symptoms through the gut-brain connection. Finch has raised over $165M and has conducted multiple clinical trials of its microbiome medicines. The company's autism program represents a particularly innovative and scientifically ambitious program given the emerging evidence that gut microbiome composition influences neurological development and behavior. Finch's work contributes to the broader scientific validation of microbiome medicine as a legitimate therapeutic class beyond C. difficile.
OpsLevel is a developer portal and service catalog for tracking service ownership, maturity scorecards, and production readiness across microservices.
OpsLevel is a developer portal platform that gives engineering organizations visibility into the services they operate, who owns them, and how mature they are relative to internal engineering standards. At its core, OpsLevel maintains a service catalog that maps every microservice, repository, and infrastructure component to a team owner, populating metadata automatically from integrations with GitHub, GitLab, PagerDuty, Datadog, and cloud providers. This catalog becomes the authoritative source of truth for answering questions like who to contact about a service, what tier of reliability it requires, and what dependencies it has — questions that are often unanswerable at engineering organizations that have grown past the point where everyone knows everything.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.